Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Embecta Corp. (EMBC : NSDQ)

• Company Description    Embecta Corp. is a pure-play diabetes care company. Embecta is based in FRANKLIN LAKES, N.J. Number of Employees: 2,100

• Price / Volume Information    Yesterday's Closing Price: $15.31 Daily Weekly Monthly 20 Day Moving Average: 482,119 shares Shares Outstanding: 58.49 (millions) Market Capitalization: $895.41 (millions) Beta: 1.12 52 Week High: $21.48 52 Week Low: $9.20 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 10.38% 8.39% 12 Week 57.19% 42.71% Year To Date -25.86% -33.80%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 300 Kimball Drive - Parsippany,NJ 07054 USA ph: 862-401-0000 fax: - investor.relations@embecta.com http://www.embecta.com

• General Corporate Information    Officers Devdatt Kurdikar - President and Chief Executive Officer David F. Melcher - Chairman Jacob Elguicze - Senior Vice President; Chief Financial Officer David J. Albritton - Director Carrie L. Anderson - Director Peer Information Embecta Corp. (CHCR) Embecta Corp. (ESRX) Embecta Corp. (MYDP) Embecta Corp. (COR) Embecta Corp. (GBCS) Embecta Corp. (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 29082K105 SIC: 3841 Fiscal Year Fiscal Year End: September Last Reported Quarter: 06/01/25 Next Expected EPS Date: 11/25/25 Share - Related Items Shares Outstanding: 58.49 Most Recent Split Date: (:1) Beta: 1.12 Market Capitalization: $895.41 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 3.92% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.60 Current Fiscal Year EPS Consensus Estimate: $2.93 Payout Ratio: 0.21 Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: -0.01 Estmated Long-Term EPS Growth Rate: 6.15% Last Dividend Paid: 08/29/2025 - $0.15 Next EPS Report Date: 11/25/25

• Fundamental Ratios P/E Current FY Estimate: 5.23 Trailing 12 Months: 5.24 PEG Ratio: 0.85 Price Ratios Price/Book: - Price/Cash Flow: 4.59 Price / Sales: 0.81 EPS Growth vs. Year Ago Period: 51.35% vs. Previous Quarter: 60.00% Sales Growth vs. Year Ago Period: 8.44% vs. Previous Quarter: 14.09% ROE 06/30/25 - -23.40 03/31/25 - -19.67 12/31/24 - -19.22 ROA 06/30/25 - 14.46 03/31/25 - 12.27 12/31/24 - 11.92 Current Ratio 06/30/25 - 2.47 03/31/25 - 2.48 12/31/24 - 2.24 Quick Ratio 06/30/25 - 1.78 03/31/25 - 1.83 12/31/24 - 1.67 Operating Margin 06/30/25 - 15.46 03/31/25 - 13.70 12/31/24 - 13.19 Net Margin 06/30/25 - 7.58 03/31/25 - 4.89 12/31/24 - 5.25 Pre-Tax Margin 06/30/25 - 9.10 03/31/25 - 5.10 12/31/24 - 2.64 Book Value 06/30/25 - -11.46 03/31/25 - -12.66 12/31/24 - -13.23 Inventory Turnover 06/30/25 - 2.35 03/31/25 - 2.27 12/31/24 - 2.36 Debt-to-Equity 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Capital 06/30/25 - - 03/31/25 - - 12/31/24 - -

Powered by Zacks Investment Research ©